Pharma-Bio Serv is a compliance, project management, and technology transfer support consulting firm, headquartered in Puerto Rico, servicing the Puerto Rico, United States, Europe and Latin America markets. Pharma-Bio Serv's core business is FDA and international agencies regulatory compliance consulting related services. The Company's global team includes leading engineering and life science professionals, quality assurance managers and directors.
Company profile
Ticker
PBSV
Exchange
Website
CEO
Victor Sanchez
Employees
Location
Fiscal year end
Industry (SIC)
Former names
LAWRENCE CONSULTING GROUP INC
SEC CIK
Corporate docs
Subsidiaries
Pharma-Bio Serv PR, Inc. • Pharma-Bio Serv US, Inc. • Pharma Serv, Inc. • Scienza Labs, Inc. • Pharma-Bio Serv S.L. • Pharma-Bio Serv Brasil Servicos de Consultoria Ltda. ...
IRS number
200653570
PBSV stock data
Latest filings (excl ownership)
ARS
2023 FY
Annual report to shareholders
8 Apr 24
DEF 14A
Definitive proxy
8 Apr 24
8-K
Results of Operations and Financial Condition
18 Mar 24
10-Q
2024 Q1
Quarterly report
18 Mar 24
10-K/A
2023 FY
Annual report (amended)
28 Feb 24
8-K
Pharma-Bio Serv Announces Full Year Results
30 Jan 24
10-K
2023 FY
Annual report
29 Jan 24
8-K
Pharma-Bio Serv Announces Special Dividend
21 Dec 23
8-K
Results of Operations and Financial Condition
14 Sep 23
10-Q
2023 Q3
Quarterly report
14 Sep 23
Latest ownership filings
Financial summary
Quarter (USD) | Jul 23 | Apr 23 | Jan 23 | Oct 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Oct 22 | Oct 21 | Oct 20 | Oct 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 2.87 mm | 2.87 mm | 2.87 mm | 2.87 mm | 2.87 mm | 2.87 mm |
Cash burn (monthly) | 1.74 mm | 947.44 k | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 15.04 mm | 8.18 mm | n/a | n/a | n/a | n/a |
Cash remaining | -12.17 mm | -5.31 mm | n/a | n/a | n/a | n/a |
Runway (months of cash) | -7.0 | -5.6 | n/a | n/a | n/a | n/a |
Institutional ownership, Q1 2021
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
10 Jan 24 | Howard Spindel | Stock Option Common Stock | Grant | Acquire A | No | No | 0.85 | 20,000 | 17.00 k | 20,000 |
10 Jan 24 | Kirk Wheeler Michel | Stock Option Common Stock | Grant | Acquire A | No | No | 0.85 | 20,000 | 17.00 k | 20,000 |
10 Jan 24 | Irving L Wiesen | Stock Option Common Stock | Grant | Acquire A | No | No | 0.85 | 20,000 | 17.00 k | 20,000 |
10 Jan 24 | Perlysky Dov | Stock Option Common Stock | Grant | Acquire A | No | No | 0.85 | 20,000 | 17.00 k | 20,000 |
5 Jan 24 | Howard Spindel | Common Stock | Gift | Acquire G | Yes | No | 0 | 1,132 | 0.00 | 42,504 |
5 Jan 24 | Howard Spindel | Common Stock | Gift | Dispose G | No | No | 0 | 1,132 | 0.00 | 0 |
5 Jan 24 | Howard Spindel | Common Stock | Payment of exercise | Dispose F | No | No | 1.06 | 18,868 | 20.00 k | 1,132 |
5 Jan 24 | Howard Spindel | Common Stock | Option exercise | Acquire M | No | No | 1 | 20,000 | 20.00 k | 20,000 |
5 Jan 24 | Howard Spindel | Stock Option Common Stock | Option exercise | Dispose M | No | No | 1 | 20,000 | 20.00 k | 0 |